| Bioactivity | PKCθ pseudosubstrate peptide inhibitor, myristoylated is a synthetic peptide that can be used to study the mechanism of action of PKCθ[1]. |
| Name | PKCθ pseudosubstrate peptide inhibitor,myristoylated |
| Sequence | {Myr}-Leu-His-Gln-Arg-Arg-Gly-Ala-Ile-Lys-Gln-Ala-Lys-Val-His-His-Val-Lys-Cys-NH2 |
| Shortening | {Myr}-LHQRRGAIKQAKVHHVKC-NH2 |
| Formula | C105H184N36O21S |
| Molar Mass | 2318.88 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Koon HW, et al. Substance P-stimulated interleukin-8 expression in human colonic epithelial cells involves protein kinase Cdelta activation. J Pharmacol Exp Ther. 2005 Sep;314(3):1393-400. |
PKCθ pseudosubstrate peptide inhibitor,myristoylated
CAS: F: C105H184N36O21S W: 2318.88
PKCθ pseudosubstrate peptide inhibitor, myristoylated is a synthetic peptide that can be used to study the mechanism of
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.